Value investing message boards image Log on |  Join ($$) Stock market forums image VF "How To" Guide        Welcome, guest! Learn about guest access               Home
• Related Discussion Forum Messages
As a ValueForum member, this section would contain CBM message board posts where the ticker symbol CBM has been mentioned by ValueForum members in posts. Learn more about guest access, and benefits of membership -- we hope you will consider joining ValueForum or trying out our service with a 24 hour trial pass.

• Latest CBM SEC Filings

Filings Format Description Filing Date File/Film Number
8-K/A  Documents [Amend] Current report, item 9.01
Acc-no: 0001564590-18-030102 (34 Act)  Size: 3 MB
2018-11-27 001-10638
8-K  Documents Current report, items 1.01, 7.01, and 9.01
Acc-no: 0001564590-18-029869 (34 Act)  Size: 4 MB
2018-11-20 001-10638
10-Q  Documents   Interactive Data Quarterly report [Sections 13 or 15(d)]
Acc-no: 0001564590-18-028270 (34 Act)  Size: 8 MB
2018-11-08 001-10638
8-K  Documents Current report, items 2.02 and 9.01
Acc-no: 0001193125-18-321797 (34 Act)  Size: 233 KB
2018-11-08 001-10638
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001209191-18-056294 Size: 5 KB
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001209191-18-056292 Size: 5 KB
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001209191-18-056290 Size: 5 KB
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001209191-18-056288 Size: 5 KB
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001209191-18-056084 Size: 11 KB
8-K  Documents Current report, items 2.01 and 9.01
Acc-no: 0001193125-18-276417 (34 Act)  Size: 18 KB
2018-09-18 001-10638
More CBM SEC Filings

Related news from
Sun, 09 Dec 2018
13:59:28 +0000
Interested In Cambrex Corporation (NYSE:CBM)? Here’s What Its Recent Performance Looks Like
Examining Cambrex Corporation's (NYSE:CBM) past track record of performance is a useful exercise for investors. It allows us to reflect on whether the company has met or exceed expectations, which Read More...
Sat, 08 Dec 2018
13:02:38 +0000
See what the IHS Markit Score report has to say about Cambrex Corp.
This means that investors who seek to profit from falling equity prices are currently targeting CBM. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
Wed, 21 Nov 2018
06:51:34 +0000
Edited Transcript of CBM earnings conference call or presentation 8-Nov-18 1:30pm GMT
Q3 2018 Cambrex Corp Earnings Call
Tue, 20 Nov 2018
18:02:21 +0000
[$$] Cambrex Buying Avista Pharma Solutions From Ampersand for $252 Million
Corp. on Tuesday said it agreed to buy Avista Pharma Solutions, a contract development, manufacturing and testing organization, from private-equity firm Ampersand Capital Partners for about $252 million. The East Rutherford, N.J.-based life-sciences company said the deal adds early-stage small-molecule development and testing services to its portfolio. Cambrex said it will fund the deal, which it expects to complete before the end of the year, with cash on hand and borrowings under its revolving credit facility, which the company will increase through its accordion feature.
Tue, 20 Nov 2018
11:40:00 +0000
Cambrex to Acquire Avista Pharma Solutions, Adding Early Stage API and Finished Dosage Form Development & Testing Services to its Global Contract Development & Manufacturing Network
-- Conference Call at 8:30 a.m. ET Today -- EAST RUTHERFORD, N.J., Nov. 20, 2018 -- Cambrex Corporation (NYSE: CBM), the leading manufacturer of small molecule innovator and.
Fri, 09 Nov 2018
15:47:01 +0000
Cleantech Building Materials: Amendment of Loan Facility
Thu, 08 Nov 2018
16:57:27 +0000
Cambrex Corp (CBM) Q3 2018 Earnings Conference Call Transcript
CBM earnings call for the period ending September 30, 2018.
Thu, 08 Nov 2018
15:45:03 +0000
Cambrex (CBM) Lags Q3 Earnings and Revenue Estimates
Cambrex (CBM) delivered earnings and revenue surprises of -16.95% and -18.16%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Thu, 08 Nov 2018
15:14:14 +0000
What Investors Should Know About Cambrex Corporation’s (NYSE:CBM) Financial Strength
Zero-debt allows substantial financial flexibility, especially for small-cap companies like Cambrex Corporation (NYSE:CBM), as the company does not have to adhere to strict debt covenants. However, it also faces higher<div><a class="permalink" href="">Read More...</a></div>
Thu, 08 Nov 2018
14:38:13 +0000
Cambrex: 3Q Earnings Snapshot
The East Rutherford, New Jersey-based company said it had profit of 79 cents per share. Earnings, adjusted for non-recurring gains, were 49 cents per share. The life sciences company posted revenue of ...
Mon, 05 Nov 2018
20:55:00 +0000
Cambrex to Announce Third Quarter 2018 Financial Results on November 8, 2018
EAST RUTHERFORD, N.J., Nov. 05, 2018 -- Cambrex Corporation (NYSE: CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients.
Mon, 05 Nov 2018
13:52:12 +0000
Cambrex Corporation (NYSE:CBM): Should The Future Outlook Worry You?
Based on Cambrex Corporation’s (NYSE:CBM) earnings update in June 2018, analyst consensus outlook seem bearish, with profits predicted to drop by -2.2% next year against the past 5-year average growth<div><a class="permalink" href="">Read More...</a></div>
Tue, 30 Oct 2018
21:01:00 +0000
3 Top Biotech Stocks to Buy Right Now
Adding these biotech stocks to portfolios at current prices could pay off.
Mon, 29 Oct 2018
17:47:21 +0000
These Fundamentals Make Cambrex Corporation (NYSE:CBM) Truly Worth Looking At
Attractive stocks have exceptional fundamentals. In the case of Cambrex Corporation (NYSE:CBM), there’s is a company with great financial health as well as a a strong track record of performance.<div><a class="permalink" href="">Read More...</a></div>
Mon, 29 Oct 2018
12:15:00 +0000
Report: Developing Opportunities within Noah, 3M, Kimberly-Clark, Cambrex, Argan, and Autohome — Future Expectations, Projections Moving into 2018
NEW YORK, Oct. 29, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
Mon, 08 Oct 2018
12:00:00 +0000
Cambrex Invests c.$3 Million to Upgrade Generic API Manufacturing Facilities at Milan, Italy Site
Cambrex Corporation (CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), and finished dosage forms, today announced that it is investing approximately $3 million to increase the capacity and efficiency of one of its cGMP manufacturing facilities at its site in Paullo, Milan, Italy. The 1,350 sq. m (approx. 14,500 sq. ft) facility manufactures intermediates and APIs under GMP conditions, and this investment is part of a campaign by Cambrex of continuous improvement across its global network of manufacturing sites. “This investment not only increases the overall capacity and capabilities of the facility, but also its flexibility, allowing us to work more efficiently,” commented Aldo Magnini, Managing Director, Cambrex Milan.

"ValueForum is an active, private, online discussion community for stock & bond market investing. In discussion forums divided into finely grained topics, you will find sophisticated investors trading tips, research, and due diligence on value stocks, income investments, forex, market news, and more. Join in - trade ideas, strategies, current news, via our unique message bulletin boards, stock ratings system, and other online tools specifically geared toward our community."

Random member testimonial: "ValueForum is a great group of very smart, sophisticated investors. We have several professionals on board managing millions of dollars, and "average Joe" investors that beat the pants off of Wall Street professionals year in and year out. ValueForum will expose you to a wealth of ideas and sectors, and keep you ahead of the curve." more testimonials »

Email / About | Privacy | Terms of Use | How To / FAQ | Msg Ticker | VF Home | My.vf | BDCs.vf | Energy.vf | REITs.vf | TA.vf
Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by ©2003 - 2018, Powered in part by Ticker TechnologiesContact Us

Stock Market Investing Forum - Trading Tips & Research - Online Message Boards